medRxiv @medrxivpreprint@qoto.org

Genomic epidemiology sheds light on the recent spatio-temporal dynamics of Yellow Fever virus and the spatial corridor that fueled its ongoing emergence in southern Brazil. https://www.medrxiv.org/content/10.1101/2023.01.13.23284525

The COVID-19 antibody responses, isotypes and glycosylation: Why SARS-CoV-2 Spike protein complex binding of IgG3 is potentiated in some and immuno-pathologies manifest. https://www.medrxiv.org/content/10.1101/2023.01.13.23284524

Data-driven Targeting of COVID-19 Vaccination Programs: An Analysis of the Evidence on Impact, Implementation, Ethics and Equity https://www.medrxiv.org/content/10.1101/2023.01.12.23284481

"You have to add your own character": Medical Student Perspectives on Observing Clinical Encounters https://www.medrxiv.org/content/10.1101/2023.01.11.23284447

The Impact of Homologous Recombination Deficiency on First-line Adjuvant Chemotherapy and First-line PARPi Maintenance Therapy in Chinese Patients with Epithelial Ovarian Cancer https://www.medrxiv.org/content/10.1101/2023.01.12.23284477

In end-stage kidney disease, inflammation, erythron abnormalities and declined kidney function tests are accompanied by increased affective symptoms, chronic-fatigue, and fibromyalgia. https://www.medrxiv.org/content/10.1101/2023.01.12.23284460

Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid https://www.medrxiv.org/content/10.1101/2023.01.12.23284439

The role of SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic review https://www.medrxiv.org/content/10.1101/2023.01.12.23284434

Effectiveness of the offer of the Smoke Free smartphone application compared with no intervention for smoking cessation: a pragmatic randomised controlled trial https://www.medrxiv.org/content/10.1101/2023.01.12.23284463

Family Vulnerability Scale: evidence of content and internal structure validity https://www.medrxiv.org/content/10.1101/2023.01.12.23284419

Galectin-3 and Heart Failure with Preserved Ejection Fraction: Clarifying an Emerging Relationship https://www.medrxiv.org/content/10.1101/2023.01.11.23284456

Comparison of different isolation periods for preventing the spread of COVID-19: a rapid systematic review and a modelling study https://www.medrxiv.org/content/10.1101/2023.01.12.23284479

Applying models of care for total hip and knee arthroplasty: External validation of a published predictive model to identify extended stay risk prior to lower-limb arthroplasty https://www.medrxiv.org/content/10.1101/2023.01.12.23284462

Genetic analysis of a large heterogeneous patient population with Familial Exudative Vitreoretinopathy https://www.medrxiv.org/content/10.1101/2023.01.11.23284445

DISPOSITION OF ADOLESCENTS TOWARD RECEIVING COVID-19 VACCINATIONS IN VILLAVICENCIO: MYTHS AND BELIEFS https://www.medrxiv.org/content/10.1101/2023.01.10.23284415

Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma: A Systematic review and meta-analysis https://www.medrxiv.org/content/10.1101/2023.01.11.23284347

Understanding the Biering-Sorensen test: contributors to extensor endurance in young adults with and without low back pain https://www.medrxiv.org/content/10.1101/2023.01.11.23284452

Quantitative Assessment of Injectable Medication Delivery Practices https://www.medrxiv.org/content/10.1101/2023.01.09.23284320

Garetosmab, an inhibitor of activin A, reduces heterotopic ossification and flare-ups in adults with fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial https://www.medrxiv.org/content/10.1101/2023.01.11.23284254

Safety and Efficacy of Oral administrated Cepharathine in Non-hospitalized, asymptomatic or mild COVID-19 patients: A Double-blind, Randomized, Placebo-controlled Trial https://www.medrxiv.org/content/10.1101/2023.01.11.23284098